Updates are available Correction dated 2019-02-13

Article History

Received: 5 October 2018

Accepted: 2 January 2019

First Online: 10 January 2019

Change Date: 13 February 2019

Change Type: Correction

Change Details: Following publication of the original article [1], the author reported that the gene/protein names of slr2131 and sll0180 were swapped in the Discussion section. The details of the correction are mentioned below:

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: RCIII is a founder, part owner and member of the Board of Directors of Curtiss Healthcare, Inc., a start-up biotech company in Gainesville, FL to develop and market vaccines against diseases of farm animals. The company has exclusive licenses to inventions and patents pertaining to vaccine technologies filed as a faculty member at Washington University in St. Louis, Arizona State University and the University of Florida. While RCIII with collaborators invented two US patents on production and recovery of biofuels from cyanobacteria, these inventions were assigned to ASU and RCIII is no longer pursuing this line of research. MPAB and SYW have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.